Searched for
PHARMACEUTICAL BUSINESS TRANSFER
RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...- Brazil, South Africa, India Key global south partners: Mauro VieiraBrazilian Foreign Minister Mauro Vieira has described Brazil, South Africa and India as major democratic partners of the Global South, stre...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- India-Japan trade could scale to USD 50 bn by 2030 as exports diversify: ASSOCHAMIndia-Japan bilateral trade has the potential to rise to USD 50 billion by 2030 from USD 27.47 billion in 2025-26, with greater export dive...
- Strikes in the Gulf changing rules behind India’s big-money betsIndia Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Trade deals open new markets for Indian medical device makers, but import risks remain: AiMeDThe EU offers the biggest long-term opportunity for Indian medical device makers, while the UK has more immediate strategic value, says AiM...
- ITC's Sanjiv Puri says CPP acquisition marks 'defining milestone' for paper businessIn a social media post, Puri welcomed the CPP workforce to ITC, saying the integration brings together two enterprises with a shared commit...
- India-Arab business chambers join hands to push trade & investment tiesIndia and Arab countries signed a trade and investment pact this week. The agreement aims to boost bilateral trade and business partnership...
- When will Bhogapuram Airport start flights?The Alluri Sitarama Raju International Airport in Bhogapuram will commence commercial flights on August 17. This new facility near Visakhap...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe next time uncertainty over the firing of missiles in the Gulf region makes you anxious, remember this: It is not the first time that gl...
- Gujarat industry seeks easier access to incentives, lower cost of doing businessIndustry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 26%The US-Iran war continues to create uncertainty for markets across the globe. But more so in India, due to the high correlation between ene...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAfter four days of relative outperformance, the Indian market is seemingly in trouble: Both the indices (the Nifty and Sensex) and market b...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- For investors with high risk-appetite: 5 mid-cap stocks from different sectors with upside potential of up to 21%Brace for trouble. The US-Iran conflict now appears to be gaining in intensity and the commodities market is taking the current spiral of v...
- Stocks in news: HDFC Bank, Vedanta Power, YES Bank, Sun Pharma, Waaree EnergiesIndian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank an...
Load More
